Biotech - Press Releases

Date	Title	Company
11-Dec-2019	Enrollment Complete for VALUE, the Prospective EU VasQ(TM) External Support Post-Market Study	Laminate Medical Technologies
11-Dec-2019	Amgen Announces 10% Increase In 2020 First Quarter Dividend	Amgen
11-Dec-2019	Biopharm Services soars into 2020 with new BioSolve Process 8	Biopharm Services
11-Dec-2019	Dr Samareh Lajaunias, Director at Combioxin Speaking at SMi's 22nd Annual Superbugs & Superdrugs Conference	SMi Group
11-Dec-2019	Invite from Lynne Ensor chair for Pharma Microbiology East Coast Conference, April 2020, Boston	SMi Group
11-Dec-2019	Hememics Biotechnologies Inc. Received $2.5 Million Investment from AMVI Partners	Hememics Biotechnologies Inc.
11-Dec-2019	Brion Bailey Joins Supply Chain Management Solutions Company Syft as Chief Commercial Officer	Syft
11-Dec-2019	Diagnosing Respiratory and Cardiac Diseases Through Voice: Vocalis Health Closes Merger and a $9M Investment Round to Create a Global Leader in Vocal Biomarkers	aMoon
11-Dec-2019	Biotech Advancements in the Immuno-Oncology Field for Pediatric and Adult Brain Tumors	FinancialNewsMedia.com
11-Dec-2019	Inceptua Appoints New CEO	Inceptua
11-Dec-2019	AGC Biologics Expands Plasmid DNA Offering	AGC Biologics
11-Dec-2019	UKI2S, Catapult Ventures and Jonathan Milner invest £500K in gene modulation newcomer Pencil Biosciences	Pencil Biosciences
10-Dec-2019	Prometheus Biosciences Appoints Dr. Thierry Dervieux as Chief Development Officer	Prometheus Biosciences, Inc.
10-Dec-2019	PharmaForce International: Post-Approval Biosimilar Drugs Encounter Obstacles When Entering into the US Market	PharmaForce International
10-Dec-2019	Envision Pharma Group evolves its Executive Leadership Team	Envision Pharma Group
10-Dec-2019	Stilla Technologies Names Key Leadership Slate to Support Global Growth of its Next-Generation Digital PCR Solution	Stilla Technologies
10-Dec-2019	Peregrine Ventures Raises $115 Million for its Fourth Fund Bringing Total Managed Funds and Co-Invest Capital to $400 Million	Peregrine
10-Dec-2019	Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion	Sanofi
10-Dec-2019	Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak	Bavarian Nordic
10-Dec-2019	bluebird bio Presents New Data from Ongoing Phase 1/2 HGB-206 Study of LentiGlobin™ Gene Therapy for Sickle Cell Disease (SCD) at 61st ASH Annual Meeting and Exposition	bluebird bio, Inc